A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval.

The Justice Department's actions on illegal vapes pales next to the scale of the problem, anti-smoking advocates say.

The Trump administration this week acknowledged it made a significant error in figures it used to help justify a fraud probe into New York’s Medicaid program ...

You could also catch up on your reading or reach out to someone special. Well, whatever you do, have a grand time. But be ...

Buyer beware: If you are an avid consumer of WAP Sensual Enhancement, the Food and Drug Administration says the pill “ may be harmful .” Want to learn about other dubious products under federal ...

In my most honest of moments, what I want from the medical community is the chance to trust it again,” a MAHA advocate writes ...

Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of ...

I didn’t expect to find myself face to face with leaders and activists from the “Make America Healthy Again” movement in respectful dialogue, or to consider inviting one into a public health classroom ...

The panel had become a flashpoint as RFK Jr.'s health department worked to limit the number of recommended childhood shots.

In this week's STATus Report, host Alex Hogan dives into how sports betting apps hook users — and how he himself fell for some too-good-to-be-true promotions.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.